TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis Therapy
Researchers from Miriam Hospital, Department of Medicine publish new studies and findings in the area of tuberculosis therapy
May 13th, 2008
A new study, 'Factors associated with failure to complete isoniazid treatment for latent tuberculosis infection in Rhode Island,' is now available. According to recent research from the United States, "The treatment of latent tuberculosis infection (LTBI) is essential for tuberculosis elimination in the United States, but the major limitation is poor adherence to therapy. To aid the design of targeted adherence interventions, we investigated the factors associated with noncompletion of isoniazid (INH) therapy for LTBI." "A retrospective analysis of patients with who failed to complete vs those who completed 9 months of INH therapy at the RISE TB Clinic (Miriam Hospital;...
Source: TB & Outbreaks Week (2008-05-13)
|
